A unique approach to dermatology and wound care

Pergamum is a first of its kind biopharmaceutical company.

Pergamum’s development pipeline currently includes five development projects with highly innovative and proprietary technologies, three of them in clinical phase.

By having several well-vetted projects within one organization with a core focus on dermatology & wound care, the individual operating units enjoy cost savings through sharing of high quality services, while the group is diversified.

Operating units

omnio_healer

 dermagen
pharmasurgics lipopeptide

Minority interests

biocis_pharma